Katherine Denby

Cooley advised Apollo Endosurgery, a medical device company, on its agreement to be acquired by Boston Scientific in an all-cash transaction with an enterprise value of approximately $615 million.

Cooley advised Allbirds, a global lifestyle brand, on its $348.3 million initial public offering of 23,221,152 shares of Class A common stock, which now trade on the Nasdaq Global Select Market under the symbol BIRD. Partners Nicole Brookshire, Peter Werner and Calise Cheng led the Cooley team advising Allbirds.

Cooley advised Etsy, a two-sided online marketplace that connect millions of passionate and creative buyers and sellers around the world, on its offering of $1 billion aggregate principal amount of 0.25% convertible senior notes due 2028. Partners Yvan-Claude Pierre, Nicole Brookshire and Rupa Briggs led the Cooley team advising Etsy.

Cooley advised Acumen Pharmaceuticals on its $160 million initial public offering of 9,999,999 shares of common stock. Acumen Pharmaceuticals, whose securities now trade on the Nasdaq Global Select Market under the symbol ABOS, is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target a key underlying cause of Alzheimer’s disease. Partner Darren DeStefano led the Cooley team.

Cooley advised UiPath, the world’s leading robotics process automation software company, on its $1.5 billion initial public offering of 27,474,393 shares of Class A common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Partners Nicole Brookshire, Eric Jensen and Matthew Dubofsky led the Cooley team advising UiPath.